Phosphate is a Specific Signal for Induction of Osteopontin Gene Expression

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2000 Jul 13

PMID 10890885

Citations 174

Authors

G R Beck Jr

B Zerler

E Moran

Affiliations

Soon will be listed here.

Abstract

Osteopontin is a phosphorylated glycoprotein secreted to the mineralizing extracellular matrix by osteoblasts during bone development. It is believed to facilitate the attachment of osteoblasts and osteoclasts to the extracellular matrix, allowing them to perform their respective functions during osteogenesis. Several other functions have been suggested for this protein, and its up-regulation is associated with various disease states related to calcification, including arterial plaque formation and the formation of kidney stones. Although expression of this gene has been demonstrated in multiple tissues, its regulation is not well understood. Our previous studies on the roles of the retinoblastoma protein (pRB) and p300/CBP in the regulation of osteoblast differentiation revealed a link between osteopontin induction and the synthesis of alkaline phosphatase. In this paper, we describe results specifically linking induction of osteopontin to the enzymatic activity of alkaline phosphatase in the medium, which results in the generation of free phosphate. This elevation of free phosphate in the medium is sufficient to signal induction of osteopontin RNA and protein. The strong and specific induction of osteopontin in direct response to increased phosphate levels provides a mechanism to explain how expression of this product is normally regulated in bone and suggests how it may become up-regulated in damaged tissue.

Citing Articles

Association of aberrant mineral metabolic markers with fracture risk in chronic kidney disease: a comprehensive meta-analysis.

Liu Y, Zhang Z, Fu C, Ye Z, Jin H, Yang X BMC Nephrol. 2025; 26(1):68.

PMID: 39934684 PMC: 11818153. DOI: 10.1186/s12882-025-03992-w.

DNA-based hydrogels for bone regeneration: A promising tool for bone organoids.

Wu X, Hu Y, Sheng S, Yang H, Li Z, Han Q Mater Today Bio. 2025; 31:101502.

PMID: 39911372 PMC: 11795821. DOI: 10.1016/j.mtbio.2025.101502.

Comparative study of bovine and synthetic hydroxyapatite in micro- and nanosized on osteoblasts action and bone growth.

Gani M, Lee G, Ardianto C, Rantam F, Lestari M, Addimaysqi R PLoS One. 2025; 20(1):e0311652.

PMID: 39854514 PMC: 11759404. DOI: 10.1371/journal.pone.0311652.

Effects of inorganic phosphate on stem cells isolated from human exfoliated deciduous teeth.

Suwittayarak R, Nowwarote N, Kornsuthisopon C, Sukarawan W, Foster B, Egusa H Sci Rep. 2024; 14(1):24282.

PMID: 39414921 PMC: 11484878. DOI: 10.1038/s41598-024-75303-6.

Prognostic Factors of Hip Fracture in Elderly: A Systematic Review.

Kalan Farmanfarma K, Yarmohammadi S, Fakharian E, Gobbens R, Mahdian M, Batooli Z Int J Prev Med. 2024; 15:42.

PMID: 39381356 PMC: 11460988. DOI: 10.4103/ijpvm.ijpvm_169_23.

References

Patarca R, Saavedra R, CANTOR H . Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene. Crit Rev Immunol. 1993; 13(3-4):225-46. View

Hoyer J, Otvos Jr L, Urge L . Osteopontin in urinary stone formation. Ann N Y Acad Sci. 1995; 760:257-65. DOI: 10.1111/j.1749-6632.1995.tb44636.x. View

Padanilam B, Martin D, Hammerman M . Insulin-like growth factor I-enhanced renal expression of osteopontin after acute ischemic injury in rats. Endocrinology. 1996; 137(5):2133-40. DOI: 10.1210/endo.137.5.8612558. View

Noda M, Vogel R, Craig A, Prahl J, DeLuca H, Denhardt D . Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc Natl Acad Sci U S A. 1990; 87(24):9995-9. PMC: 55301. DOI: 10.1073/pnas.87.24.9995. View

Miyauchi A, Alvarez J, Greenfield E, Teti A, Grano M, Colucci S . Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem. 1991; 266(30):20369-74. View

Smith J, Denhardt D . Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities. J Cell Biochem. 1987; 34(1):13-22. DOI: 10.1002/jcb.240340103. View

Singh K, Deonarine D, Shanmugam V, Senger D, Mukherjee A, Chang P . Calcium-binding properties of osteopontin derived from non-osteogenic sources. J Biochem. 1993; 114(5):702-7. DOI: 10.1093/oxfordjournals.jbchem.a124240. View

Oldberg A, Franzen A, Heinegard D . Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci U S A. 1986; 83(23):8819-23. PMC: 387024. DOI: 10.1073/pnas.83.23.8819. View

Senger D, Perruzzi C, Gracey C, Papadopoulos A, Tenen D . Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res. 1988; 48(20):5770-4. View

10.

Vanacker J, Delmarre C, Guo X, Laudet V . Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha. Cell Growth Differ. 1998; 9(12):1007-14. View

11.

Fleisch H, Russell R, BISAZ S, Muhlbauer R, Williams D . The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo. Eur J Clin Invest. 1970; 1(1):12-8. DOI: 10.1111/j.1365-2362.1970.tb00591.x. View

12.

Rodan G . Osteopontin overview. Ann N Y Acad Sci. 1995; 760:1-5. DOI: 10.1111/j.1749-6632.1995.tb44614.x. View

13.

Franzen A, Heinegard D . Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J. 1985; 232(3):715-24. PMC: 1152943. DOI: 10.1042/bj2320715. View

14.

Palmer G, Bonjour J, Caverzasio J . Expression of a newly identified phosphate transporter/retrovirus receptor in human SaOS-2 osteoblast-like cells and its regulation by insulin-like growth factor I. Endocrinology. 1997; 138(12):5202-9. DOI: 10.1210/endo.138.12.5561. View

15.

Mayol X, Grana X . pRB, p107 and p130 as transcriptional regulators: role in cell growth and differentiation. Prog Cell Cycle Res. 1997; 3:157-69. DOI: 10.1007/978-1-4615-5371-7_13. View

16.

Reinholt F, Hultenby K, Oldberg A, Heinegard D . Osteopontin--a possible anchor of osteoclasts to bone. Proc Natl Acad Sci U S A. 1990; 87(12):4473-5. PMC: 54137. DOI: 10.1073/pnas.87.12.4473. View

17.

Denhardt D, Noda M . Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl. 1999; 30-31:92-102. View

18.

Liaw L, Birk D, Ballas C, Whitsitt J, Davidson J, Hogan B . Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest. 1998; 101(7):1468-78. PMC: 508725. DOI: 10.1172/JCI2131. View

19.

Williams G, SALLIS J . Structure--activity relationship of inhibitors of hydroxyapatite formation. Biochem J. 1979; 184(1):181-4. PMC: 1161691. DOI: 10.1042/bj1840181. View

20.

Sudo H, Kodama H, Amagai Y, Yamamoto S, Kasai S . In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol. 1983; 96(1):191-8. PMC: 2112252. DOI: 10.1083/jcb.96.1.191. View